Tadalafil 10mg + bremelanotide 10mg + pregnenolone 10mg — blood-flow support plus bremelanotide, the active ingredient in an FDA-approved injectable therapy for certain women. This compounded oral formula is not FDA-approved.
From $130 for 6 doses
Contains bremelanotide, the active ingredient in an FDA-approved injectable for acquired, generalized hypoactive sexual desire disorder in premenopausal women. This compounded oral form is not FDA-approved.
Central desire-pathway support plus peripheral blood-flow support, when prescribed by a licensed provider.
Pregnenolone rounds out the formula.
One dissolvable tablet before intimacy, if prescribed.
A 5-minute online health questionnaire — no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose adjustments and refills handled online.
Your assessment takes about 5 minutes. A licensed provider will review your health history and determine whether treatment is appropriate.
Start Assessment — provider will determine if appropriate →
PT-141 (bremelanotide) is a subcutaneous injection that acts on melanocortin pathways in the central nervous system, prescribed when a licensed provider determines it is appropriate.
Tadalafil 10mg + pregnenolone 10mg — genital blood-flow support paired with a neurosteroid precursor.